EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension

Martha Hinton, James A Thliveris, Grant M Hatch, Shyamala Dakshinamurti

Frontiers in Physiology · 29.03.2023 · 14

DOI: 10.3389/fphys.2023.1144574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 29.03.2023. Verfasst von Martha Hinton und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biology of Breathing Group, Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypoxic persistent pulmonary hypertension in the newborn (PPHN) is usually treated with oxygen and inhaled nitric oxide (NO), both pulmonary arterial relaxants. But treatment failure with NO occurs in 25% of cases. We previously demonstrated that 72 h exposure to hypoxia, modeling PPHN, sensitized pulmonary artery smooth muscle cells (PASMC) to the contractile agonist thromboxane and inhibited relaxant adenylyl cyclase (AC) activity.

Methods

In this study, we examined the effects of sodium nitroprusside (SNP), as NO donor, on the thromboxane-mediated contraction and NO-independent relaxation pathways and on reactive oxygen species (ROS) accumulation in PASMC. In addition, we examined the effect of the peroxynitrite scavenger 5,10,15,20-Tetrakis (4-sulfonatophenyl)porphyrinato Iron (III) (FeTPPS) on these processes.

Results

Exposure of PASMC to 72 h hypoxia increased total intracellular ROS compared to normoxic control cells and this was mitigated by treatment of cells with either SNP or FeTPPS. Total protein nitrosylation was increased in hypoxic PASMC compared to controls. Both normoxic and hypoxic cells treated with SNP exhibited increased total protein nitrosylation and intracellular nitrite; this was reduced by treatment with FeTPPS. While cell viability and mitochondrial number were unchanged by hypoxia, mitochondrial activity was decreased compared to controls; addition of FeTPPS did not alter this. Basal and maximal mitochondrial metabolism and ATP turnover were reduced in hypoxic PASMC compared to controls. Hypoxic PASMC had higher basal Ca2+, and a heightened peak Ca2+ response to thromboxane challenge compared to controls. Addition of SNP further elevated the peak Ca2+ response, while addition of FeTPPS brought peak Ca2+ response down to control levels. AC mediated relaxation was impaired in hypoxic PASMC compared to controls but was normalized following treatment with FeTPPS. Addition of SNP inhibited adenylyl cyclase activity in both normoxic and hypoxic PASMC. Moreover, addition of the Ca2+ chelator BAPTA improved AC activity, but the effect was minimal.

Discussion

We conclude that NO independently augments contraction and inhibits relaxation pathways in hypoxic PASMC, in part by a mechanism involving nitrogen radical formation and protein nitrosylation. These observations may partially explain impaired effectiveness of NO when treating hypoxic pulmonary hypertension.

Schlagwörter

Stichwörter der Autor:innen

adenylyl cyclasecalciumhypoxianitric oxidepersistent pulmonary hypertension of the newbornsmooth musclethromboxane

Autor:innen und Institutionen

  • Biology of Breathing Group, Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
  • Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB, Canada.
  • Department of Human Anatomy and Cell Science, University of Manitoba, Winnipeg, MB, Canada.
  • Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada.
  • Department of Pediatrics, Section of Neonatology, Health Sciences Centre, Winnipeg, MB, Canada.

Zitieren

APA

Hinton, M., Thliveris, J. A., Hatch, G. M., & Dakshinamurti, S. (2023). Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1144574

Vancouver

Hinton M, Thliveris JA, Hatch GM, Dakshinamurti S. Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension. Frontiers in Physiology. 2023;14. doi:10.3389/fphys.2023.1144574

BibTeX
@article{Hinton2023,
  author = {Hinton, Martha and Thliveris, James A and Hatch, Grant M and Dakshinamurti, Shyamala},
  title = {Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension},
  journal = {Frontiers in Physiology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphys.2023.1144574}
}
Kostenlos starten →